The primary purpose of the Teen Pregnancy Prevention (TPP) Early Innovation Program is to establish two independent intermediaries that will select, fund, and support a portfolio of innovators across the country to design, test, and refine interventions to advance adolescent health and prevent teen pregnancy.
The purpose of this funding announcement is to have a significant impact on reducing rates of teen pregnancy and existing disparities by replicating evidence-based Teen Pregnancy Prevention (TPP) programs to scale in at least 3 settings in communities and with populations at greatest need.
The purpose of this funding announcement is to increase the number of evidence-based Teen Pregnancy Prevention (TPP) interventions available by rigorously evaluating new or innovative approaches for preventing teen pregnancy and related risk behaviors.
The purpose of this Funding Opportunity Announcement (FOA) is to examine delivery models of HIV-focused services (testing, linkage, engagement and retention in care) for high risk or already HIV+ infected youth and young adults. Applications should incorporate substance use into study aims and service delivery objectives should address access to substance use prevention, screening, & treatment
The purpose of this research opportunity is to rigorously evaluate innovative interventions designed for young men aged 15-24 years old to reduce their risk of fathering a teen pregnancy that can be feasibly implemented in target settings (e.g., clinics, schools, community settings, youth-serving organizations, correctional settings).
Grant Amount: Estimated Amount of this Competition: $1,500,000,000.00. This announcement solicits applications for the fiscal year (FY) 2015 Ryan White HIV/AIDS Program (RWHAP) Part B Base, AIDS Drug Assistance Program (ADAP) Base, Pacific Island Jurisdiction Part B/ADAP Base, ADAP Supplemental, Minority AIDS Initiative (MAI), and Emerging Communities. The purpose of this grant program is to assist States and Territories in developing and/or enhancing access to a comprehensive continuum of high quality HIV care and treatment for low-income people living with HIV (PLWH).
The purpose of the RWHAP Part C EIS Program is to provide HIV primary care in the outpatient setting. Applicants must propose to provide a comprehensive continuum of outpatient HIV primary care services in the designated service area including: 1) targeted HIV counseling, testing, & referral; 2) medical evaluation and clinical care; 3) other primary care services; & 4) referrals to other services.
Grant Amount: Approximate Total Fiscal Year Funding: $77,120,323; Approximate Total Project Period Funding: $385,601,610. The Centers for Disease Control and Prevention (CDC) announces the availability of Fiscal Year (FY) 2015 funds to implement funding opportunity announcement (FOA) CDC-RFA-PS15-1501 Tuberculosis (TB) Elimination and Laboratory Cooperative Agreement (CoAg). TB CoAg funds support TB Prevention and Control (P&C) activities, TB programs’ Human Resources Development (HRD) activities, and Public Health Laboratory Strengthening activities according to formulas that reflect TB
Grant Amount: Approximate Total Fiscal Year Funding: approximately $4,000,000; Approximate Total Project Period Funding: approximately $15,000,000. CDC seeks to support state and local public health efforts to increase the prevention effectiveness of public health interventions. Timely models and economic analyses support both of these goals.
This announcement solicits applications for the Ryan White HIV/AIDS Program (RWHAP)States/Territories Part B Supplemental Grant Program. The purpose of this program is to supplement the HIV care and treatment services provided by the States/Territories through RWHAP Part B and AIDS Drug Assistance Program (ADAP) Base funds. The amount of funding is determined by the applicant’s ability to demonstrate the need in the State/Territory based on an objective and quantified basis.